100 related articles for article (PubMed ID: 23294052)
1. Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression.
Dubovsky SL
Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):207-14. PubMed ID: 23294052
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
Detke HC; DelBello MP; Landry J; Usher RW
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
5. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
[TBL] [Abstract][Full Text] [Related]
6. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
[TBL] [Abstract][Full Text] [Related]
7. Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.
Dubé S; Tollefson GD; Thase ME; Briggs SD; Van Campen LE; Case M; Tohen M
Bipolar Disord; 2007 Sep; 9(6):618-27. PubMed ID: 17845277
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
Deeks ED; Keating GM
Drugs; 2008; 68(8):1115-37. PubMed ID: 18484802
[TBL] [Abstract][Full Text] [Related]
9. Effect of comorbid anxiety on treatment response in bipolar depression.
Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
Tamayo JM; Sutton VK; Mattei MA; Diaz B; Jamal HH; Vieta E; Zarate CA; Fumero I; Tohen M
J Clin Psychopharmacol; 2009 Aug; 29(4):358-61. PubMed ID: 19593175
[TBL] [Abstract][Full Text] [Related]
11. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
Bobo WV; Shelton RC
Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine plus fluoxetine for bipolar disorder: a systematic review and meta-analysis.
Silva MT; Zimmermann IR; Galvao TF; Pereira MG
J Affect Disord; 2013 Apr; 146(3):310-8. PubMed ID: 23218251
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
Citrome L
Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
17. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
Vieta E; Berk M; Wang W; Colom F; Tohen M; Baldessarini RJ
J Affect Disord; 2009 Dec; 119(1-3):22-7. PubMed ID: 19324419
[TBL] [Abstract][Full Text] [Related]
18. Use of olanzapine in the treatment of bipolar I disorder.
Lieberman DZ; Goodwin FK
Expert Rev Neurother; 2004 Sep; 4(5):759-67. PubMed ID: 15853503
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
20. Drug safety evaluation of olanzapine/fluoxetine combination.
Cristancho MA; Thase ME
Expert Opin Drug Saf; 2014 Aug; 13(8):1133-41. PubMed ID: 24972823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
